Jazz Pharmaceuticals plc — Director's Dealing 2011

Jun 2, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JAZZ PHARMACEUTICALS INC (JAZZ)
CIK: 0001232524
Period of Report: 2011-05-31

Reporting Person: Wissel Janne LT (SVP, Chief Regulatory Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-05-31	Common Stock	J	1323	$.85	Acquired	48544	Direct

Footnotes

F1: Shares acquired through a qualified Section 423 Employee Stock Purchase Plan.